-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Maintains Buy on Boston Scientific, Lowers Price Target to $55

Benzinga·10/26/2026 15:25:17
Listen to the news
Stifel analyst Rick Wise maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $60 to $55.